{"gene":"MEIS2","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":1998,"finding":"MEIS2 (MRG1) forms a trimeric complex with PBX1b and PDX1 on the B element of the pancreatic elastase I gene enhancer in acinar cells, switching PDX1 transcriptional activity from beta-cell-type activation to acinar-cell-type activity dependent on other enhancer elements; beta-cell lines lack PBX1b and MRG1/MEIS2, preventing trimeric complex formation.","method":"Co-immunoprecipitation, electrophoretic mobility shift assay, transcriptional reporter assays in acinar and beta-cell lines, B element mutagenesis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (Co-IP, EMSA, reporter assays, mutagenesis) in a single rigorous study establishing trimeric complex and functional consequence","pmids":["9710595"],"is_preprint":false},{"year":1999,"finding":"Ectopic Meis2 expression in the chick limb bud severely disrupts distal limb outgrowth and represses distal genes; Meis2 is normally restricted to proximal regions by BMPs and Hoxd genes, establishing a proximal identity that antagonizes distal outgrowth.","method":"Retroviral misexpression in chick limb buds, in situ hybridization for distal markers, epistasis with BMP and Hoxd gene manipulations","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function misexpression with defined phenotypic readout and epistasis, replicated across multiple gene combinations","pmids":["10619030"],"is_preprint":false},{"year":2000,"finding":"Meis2 isoforms (a-d) bind the ACT activator sequence of the dopamine D1A receptor gene promoter and activate transcription; TGIF competes with Meis2 for binding to this site and represses Meis2-induced activation. Splice variant Meis2e, with a truncated homeodomain, cannot bind DNA or activate transcription but acts as a dominant-negative inhibitor of Meis2d-induced transcription.","method":"EMSA (DNA binding assay), luciferase transcriptional reporter assays in multiple cell types, dominant-negative overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct DNA-binding assays combined with reporter assays and dominant-negative mutagenesis, single lab with multiple orthogonal methods","pmids":["10764806"],"is_preprint":false},{"year":2009,"finding":"Meis2 physically interacts with Otx2 and competes with the Groucho co-repressor Tle4 (Grg4) for binding to Otx2, thereby relieving Otx2 transcriptional repression and restoring its activator function during tectal development in chick.","method":"Co-immunoprecipitation, Otx2-dependent reporter assay, in ovo electroporation gain- and loss-of-function in chick mesencephalic vesicle","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP demonstrating direct interaction, reporter assay demonstrating functional consequence, and in vivo electroporation phenotype, single lab with multiple orthogonal methods","pmids":["19736326"],"is_preprint":false},{"year":2010,"finding":"The homothorax (Hth) domain of Meis2 autoinhibits its C-terminal transcriptional activation domain; this autoinhibition is partially relieved by Pbx1 binding to the Hth domain. A splice variant equivalent to Meis3.2 that disrupts the Hth domain derepresses the activation domain and weakens Pbx1 interaction.","method":"Transcriptional reporter assays, domain deletion and fusion constructs, Gal4-based activation domain assays, co-immunoprecipitation for Pbx1 interaction","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple deletion/fusion constructs with reporter assays and Co-IP demonstrating autoinhibition mechanism, single lab with multiple orthogonal methods","pmids":["20553494"],"is_preprint":false},{"year":2011,"finding":"Meis2 interacts with Klf4 and Pbx1 to cooperatively activate transcription of p15(Ink4a) and E-cadherin; Meis2d transcriptional activation domain is required for this cooperative activation, and reducing endogenous Meis2 or Pbx1 decreases p15 expression and increases S-phase entry.","method":"Co-immunoprecipitation, luciferase reporter assays, ChIP, siRNA knockdown of endogenous Meis2/Pbx1 with cell cycle readout, promoter mutagenesis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, reporter assays, ChIP, and functional knockdown with cell-cycle phenotype, single lab with multiple orthogonal methods","pmids":["21746878"],"is_preprint":false},{"year":2012,"finding":"Meis2 physically interacts with Pax3 and Pax7 in the tectal anlage; Meis2 acts downstream of Pax3/Pax7 and requires balanced expression of both proteins, as demonstrated by in ovo electroporation in chick mesencephalic vesicle.","method":"Co-immunoprecipitation, in ovo electroporation gain- and loss-of-function, in situ hybridization","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP plus in vivo epistasis by electroporation, single lab","pmids":["22390724"],"is_preprint":false},{"year":2013,"finding":"Meis2 forms a biochemical complex with Pax6 and Dlx2 in the olfactory bulb neurogenic system; ChIP identified doublecortin and tyrosine hydroxylase as direct Meis2 target genes in newly generated neurons; Meis2 activity is cell-autonomously required for neuronal fate acquisition by SVZ progenitors and for generation of dopaminergic periglomerular neurons.","method":"Co-immunoprecipitation (Meis2-Pax6-Dlx2 complex), chromatin immunoprecipitation (doublecortin and TH as direct targets), retroviral dominant-negative and siRNA knockdown in vivo and in vitro","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, ChIP, and retroviral loss-of-function with defined cellular phenotype, single lab with multiple orthogonal methods","pmids":["24284204"],"is_preprint":false},{"year":2013,"finding":"Polycomb RING1B binds the Meis2 promoter and a 3'-end RING1B-binding site (RBS) to repress Meis2; during early midbrain development, a midbrain-specific enhancer (MBE) forms a tripartite interaction with the promoter and RBS in a RING1-dependent manner, and subsequent dissociation of the RBS allows promoter-MBE engagement to activate Meis2 expression.","method":"ChIP, 3C/chromatin conformation capture, Ring1B conditional knockout mouse, in situ hybridization","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP and 3C demonstrating tripartite interaction, genetic knockout model, multiple orthogonal methods in single lab","pmids":["24374176"],"is_preprint":false},{"year":2014,"finding":"MEIS2 is required for neuroblastoma cell survival and M-phase progression; MEIS2 functions as a transcriptional activator of the MuvB-BMYB-FOXM1 complex, and FOXM1 is a direct transcriptional target of MEIS2 required for MEIS2-induced upregulation of mitotic genes.","method":"siRNA knockdown, ectopic overexpression with proliferation/tumorigenicity assays, gene expression profiling, ChIP (FOXM1 as direct target), rescue experiments","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP identifying direct target, knockdown with M-phase arrest phenotype, rescue experiments, single lab with multiple orthogonal methods","pmids":["25210800"],"is_preprint":false},{"year":2015,"finding":"RING1A and RING1B (PRC1 components) are required for repression of Meis2 (and Meis1) in the distal forelimb bud; additional deletion of Meis2 in Ring1A/B-deficient mice partially restores distal gene expression and limb formation, establishing a RING1-MEIS2 repression axis critical for proximal-distal specification.","method":"Conditional double knockout mice (Ring1A/B), Meis2 compound knockout rescue experiment, in situ hybridization, RING1B ChIP","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis (triple mutant rescue), ChIP, and in vivo phenotype, multiple orthogonal approaches","pmids":["26674308"],"is_preprint":false},{"year":2015,"finding":"Conditional inactivation of Meis2 in neural crest cells (AP2α-IRES-Cre) causes defects in craniofacial skeleton (cranial bones and cartilages), persistent truncus arteriosus, and cranial nerve abnormalities; systemic Meis2 knockout results in embryonic lethality by E14 with hemorrhaging.","method":"Conditional knockout mouse (AP2α-IRES-Cre; Meis2fl/fl), systemic knockout mouse, histology, immunofluorescence","journal":"BMC developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — tissue-specific conditional KO with defined phenotypic readouts in neural crest-derived tissues, multiple conditional alleles used","pmids":["26545946"],"is_preprint":false},{"year":2016,"finding":"MEIS2 binds directly to the Runt domain of AML1-ETO; high MEIS2 expression impairs repressive DNA binding of AML1-ETO and induces increased expression of proto-oncogene YES1; MEIS2 collaborates with AML1-ETO to induce AML in mice.","method":"Co-immunoprecipitation (MEIS2-AML1-ETO Runt domain interaction), shRNA knockdown in AML cell lines, murine leukemia model, gene expression analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP demonstrating direct binding to Runt domain, in vivo leukemia model, and functional knockdown, single lab","pmids":["27346355"],"is_preprint":false},{"year":2016,"finding":"In castration-resistant prostate cancer, MEIS2 is repressed by miR-196b-3p as part of a constitutively activated feedforward circuit composed of IκBα/NF-κB(p65), miR-196b-3p, Meis2, and PPP3CC that drives stem cell transcription factor expression and tumorigenicity.","method":"miRNA target validation, luciferase reporter assay, siRNA/shRNA knockdown of circuit components, in vivo tumorigenicity assays, NF-κB reporter assays","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — multiple functional assays placing MEIS2 in a feedforward signaling circuit, single lab","pmids":["28041912"],"is_preprint":false},{"year":2018,"finding":"MEIS2 nuclear accumulation in adult SVZ-derived progenitor cells is controlled by arginine methylation: methylation of a conserved arginine on MEIS2 (near CRM1 and PBX1 binding sites) impairs interaction with the nuclear export receptor CRM1 without affecting PBX1 dimerization, thereby allowing MEIS2 nuclear accumulation required for neuronal differentiation.","method":"Co-immunoprecipitation (CRM1 and PBX1 interactions), arginine methylation site mutagenesis, subcellular fractionation, retroviral constructs in SVZ progenitors, EGFR signaling manipulation","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — site-directed mutagenesis of PTM site, Co-IP showing differential binding, fractionation demonstrating nuclear localization consequence, single lab with multiple orthogonal methods","pmids":["29641989"],"is_preprint":false},{"year":2018,"finding":"Variant PRC1 incorporating PCGF3 and PCGF5 represses Meis2 in the distal forelimb bud by antagonizing retinoic acid-related signals; PcG factors and RA-related signals compete to polarize Meis2 expression along the proximal-distal axis.","method":"Conditional knockout mice (PCGF3/5), ChIP, mathematical modeling, RA pathway manipulation, in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP, conditional KO mice, and epistasis with RA pathway, multiple orthogonal methods in single lab","pmids":["30190278"],"is_preprint":false},{"year":2018,"finding":"MEIS2 regulates the endothelial-to-hematopoietic transition (EHT) during hematopoietic differentiation of human embryonic stem cells; TAL1 acts as a downstream gene mediating MEIS2 function during early hematopoiesis, as deletion of MEIS2 suppresses TAL1 expression and impairs hemogenic endothelial specification.","method":"CRISPR/Cas9 MEIS2 deletion in hESCs, hematopoietic differentiation assays, whole-genome gene profiling, TAL1 rescue experiments","journal":"Stem cell research & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with defined differentiation phenotype, TAL1 identified as downstream target by rescue, single lab","pmids":["30526668"],"is_preprint":false},{"year":2019,"finding":"PTBP1 upregulates the MEIS2-L splice variant to promote bladder cancer cell migration and invasion; overexpression of MEIS2-L rescues the reduced migration and invasion caused by PTBP1 knockdown, and MEIS2-L is associated with increased MMP9 expression.","method":"siRNA knockdown of PTBP1, alternative splicing analysis, MEIS2-L overexpression rescue experiments, invasion and migration assays, in vivo lymph node metastasis model","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — splicing regulation demonstrated by knockdown and rescue, in vivo and in vitro functional assays, single lab","pmids":["30742945"],"is_preprint":false},{"year":2019,"finding":"MEIS2 is a substrate of the CRL4-cereblon (CRBN) E3-ubiquitin ligase complex; MEIS2 was identified as a cereblon substrate by crystal structure and biochemical screen, and IMiDs can block MEIS2 from binding CRBN, facilitating CRL4CRBN-IMiD E3 ubiquitin ligase activity. MEIS2 regulates Cyclin E/CCNE1 expression and modulates IMiD activity in multiple myeloma cells.","method":"Crystal structure (biochemical identification as CRBN substrate), RNA interference knockdown, cell viability and apoptosis assays, BET inhibitor modulation of MEIS2 expression","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — crystal structure identification as CRBN substrate cited, functional knockdown with proliferation/apoptosis phenotype, single lab; full structural data in referenced prior work","pmids":["30975979"],"is_preprint":false},{"year":2019,"finding":"siRNA-mediated simultaneous knockdown of Rb1 and Meis2 in adult cardiomyocytes promotes cell cycle reentry, increases cardiomyocyte number, decreases cell size, increases mononucleated cardiomyocytes in vitro, and in vivo reduces infarct size and improves cardiac function post-myocardial infarction, implicating Meis2 as a senescence-associated cell cycle inhibitor in adult cardiomyocytes.","method":"siRNA knockdown in adult rat and human iPSC-derived cardiomyocytes, EdU/PH3/Ki67/Aurora B immunostaining, hydrogel siRNA delivery post-MI in vivo, echocardiography","journal":"Journal of the American Heart Association","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA KD with cell cycle and cardiac functional phenotypes in vitro and in vivo, single lab with multiple orthogonal proliferation markers","pmids":["31315484"],"is_preprint":false},{"year":2020,"finding":"MEIS2 directly regulates key osteogenic genes in palatal neural crest cells as determined by ChIP-seq; MEIS2 physically interacts with SHOX2, and SHOX2 is a direct downstream target of MEIS2, with genome-wide MEIS2-SHOX2 co-occupancy identified by comparative ChIP-seq. Wnt1-Cre-mediated Meis2 inactivation results in secondary palate cleft and absence of palatal bones.","method":"ChIP-seq, RNA-seq, ATAC-seq, Wnt1-Cre conditional knockout mouse, Co-immunoprecipitation (MEIS2-SHOX2 physical interaction), de novo motif analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP-seq, ATAC-seq, RNA-seq, Co-IP, and conditional KO with palatal bone phenotype, multiple orthogonal methods in single study","pmids":["32169905"],"is_preprint":false},{"year":2020,"finding":"Meis2 inactivation in cranial neural crest cells results in loss of Sonic hedgehog signaling in oropharyngeal epithelium and impaired patterning of the first pharyngeal arch (PA1) along lateral-medial and oral-aboral axes, leading to hypoplastic tongue and ectopic mandibular ossification.","method":"Conditional knockout mouse (Wnt1-Cre;Meis2fl/fl), in situ hybridization for Shh pathway components, expression analysis of Hand1/2, Dlx5, Barx1, Gsc","journal":"Biology open","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional neural crest KO with defined Shh pathway placement and craniofacial phenotype, single lab","pmids":["32616504"],"is_preprint":false},{"year":2021,"finding":"Meis2 is required for inner ear formation: hindbrain-specific Meis2 expression is essential for otic vesicle formation, and inner-ear-specific Meis2 knockout leads to aberrant cochlear duct coiling. ChIP-seq of an otic cell line combined with transcriptomics identified direct candidate Meis2 target genes in cochlear morphogenesis.","method":"Tissue-specific conditional knockout mice (hindbrain and inner-ear specific Cre lines), RNA-seq of Meis2 mutant otic vesicles, ChIP-seq in otic cell line","journal":"Frontiers in cell and developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — tissue-specific conditional KOs with defined phenotypes, ChIP-seq for direct targets, multiple orthogonal methods in single study","pmids":["34124068"],"is_preprint":false},{"year":2022,"finding":"Dlx1/2 drives Meis2 expression in the lateral ganglionic eminence (LGE) subventricular zone through enhancer hs599; Meis2 directly binds the Zfp503 and Six3 promoters and is required for their expression to specify D1 and D2 medium-sized spiny neurons (MSNs) respectively; Meis2 deletion causes a large reduction in striatal MSNs due to a block in differentiation.","method":"Conditional knockout mouse (Meis2fl/fl), ChIP (direct binding to Zfp503 and Six3 promoters), in situ hybridization, Dlx1/2 knockout epistasis, enhancer hs599 characterization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP demonstrating direct target binding, conditional KO with differentiation block phenotype, genetic epistasis with Dlx1/2, multiple orthogonal methods","pmids":["35156680"],"is_preprint":false},{"year":2024,"finding":"Meis2 is a direct substrate of the intracellular protease calpain-2 (CAPN2/CAPNS1 complex); phosphorylation at conserved serine/threonine residues or dimerization with PBX1 reduces MEIS2 sensitivity to calpain-2 cleavage. Calpain-2 activity is high in SVZ stem/progenitor cells and declines during neuronal differentiation, inversely correlated with MEIS2 full-length stability; blocking calpain-2 or expressing cleavage-insensitive MEIS2 increases neuron production.","method":"In vitro calpain-2 cleavage assay (reconstituted), phosphorylation site mutagenesis, Co-IP (PBX1 dimerization), immunofluorescence in adult V-SVZ, calpain-2 overexpression/inhibition in progenitor cells, cleavage-insensitive MEIS2 overexpression","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstituted cleavage assay, site-directed mutagenesis, Co-IP, and in vivo neurogenic functional readout, single lab with multiple orthogonal methods","pmids":["38305737"],"is_preprint":false},{"year":2024,"finding":"Meis2 is specifically expressed in cutaneous low-threshold mechanoreceptors (LTMRs) in mice, dependent on target-derived signals; LTMRs lacking Meis2 survive and are normally specified but show markedly impaired end-organ innervation morphology, altered electrophysiological properties, and an altered transcriptome, resulting in impaired sensory-evoked behavioral responses.","method":"Conditional knockout mouse (LTMR-specific Cre lines), in vivo electrophysiology, behavioral touch response assays, immunofluorescence for end-organ morphology, RNA-seq","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — tissue-specific conditional KO with electrophysiological and behavioral phenotypes, RNA-seq, multiple orthogonal methods in single study","pmids":["38386003"],"is_preprint":false},{"year":2026,"finding":"OGT-mediated O-GlcNAcylation of MEIS2 at serine 237 maintains MEIS2 protein stability by inhibiting its ubiquitination; reduced O-GlcNAcylation leads to increased MEIS2 ubiquitination and degradation, impairing osteogenic homeostasis in palatal development.","method":"O-GlcNAc-IP, site-directed mutagenesis (Ser237), ubiquitination assay, zebrafish OGT loss-of-function model, Western blot for protein stability, cleft palate mouse model","journal":"International journal of oral science","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — O-GlcNAcylation site identified by mutagenesis, ubiquitination assay showing stability regulation, in vivo zebrafish model, single lab","pmids":["41936590"],"is_preprint":false},{"year":2025,"finding":"CDK4/6 inhibition accelerates displacement of MEIS2 from CRBN by IMiDs and destabilizes MEIS2 protein while increasing CRBN, enhancing CRL4CRBN-mediated ubiquitination of IKZF3 and IKZF1 for degradation; MEIS2 also promotes BCMA expression and antagonizes IMiD/CELMoD-mediated BCMA repression in myeloma cells.","method":"Biochemical displacement assay (MEIS2-CRBN), protein stability assays, ubiquitination assays for IKZF1/3, BCMA expression analysis, ex vivo primary bone marrow myeloma cell experiments with CDK4/6 inhibitors and IMiDs","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical binding/displacement and ubiquitination assays with functional ex vivo validation, preprint not yet peer-reviewed","pmids":["41279046"],"is_preprint":true},{"year":2025,"finding":"In developing neocortex, Rbfox proteins induce a progenitor-to-neuron isoform switch in Meis2; the progenitor isoform of Meis2 promotes Tgfb3 transcription, while the neuron isoform promotes neuronal differentiation, demonstrating that alternative splicing of Meis2 generates functionally distinct isoforms with different transcriptional targets.","method":"Cell-type-specific RNA-seq, Rbfox1/2/3 conditional triple knockout in neocortex, Meis2 isoform overexpression with Tgfb3 promoter reporter assay, neuronal migration assay","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — isoform-specific overexpression with reporter assay demonstrating differential transcriptional targets, Rbfox triple KO for splicing mechanism, preprint","pmids":["bio_10.1101_2024.09.09.612108"],"is_preprint":true}],"current_model":"MEIS2 is a TALE-class homeodomain transcription factor that functions primarily as a transcriptional activator (through a C-terminal activation domain subject to autoinhibition by its Hth domain) by forming context-dependent complexes with PBX1, Pax6, Dlx2, Otx2, Pax3/7, Klf4, and PDX1 to regulate target genes (including doublecortin, tyrosine hydroxylase, Zfp503, Six3, SHOX2, FOXM1, and osteogenic genes); its activity and stability are controlled post-translationally by arginine methylation (which impairs CRM1-mediated nuclear export to promote neuronal differentiation), O-GlcNAcylation at Ser237 (which inhibits ubiquitination and stabilizes the protein), calpain-2-mediated proteolytic cleavage (reduced by PBX1 dimerization or phosphorylation), and by the CRL4-cereblon E3 ubiquitin ligase whose access is modulated by IMiDs; in development, Meis2 is epigenetically repressed in distal limb and early embryo by PRC1/RING1B complexes and activated in the midbrain by a tissue-specific enhancer-promoter topological interaction; it plays essential roles in proximal limb identity, cranial and cardiac neural crest development, striatal MSN fate specification, adult SVZ neurogenesis, inner ear morphogenesis, and sensory mechanoreceptor end-organ innervation."},"narrative":{"mechanistic_narrative":"MEIS2 is a TALE-class homeodomain transcription factor that assembles context-dependent regulatory complexes to control cell-fate specification across multiple developmental programs [PMID:9710595, PMID:24284204]. It functions principally as a transcriptional activator whose C-terminal activation domain is autoinhibited by its homothorax (Hth) domain, an autoinhibition partially relieved by PBX1 binding, while splice variants disrupting the Hth domain or homeodomain can derepress activation or act as dominant negatives [PMID:10764806, PMID:20553494]. Through DNA binding and partner-dependent complexes with PBX1/PDX1, Pax6/Dlx2, Otx2, Pax3/7, Klf4, and SHOX2, MEIS2 directs distinct transcriptional outputs—switching PDX1 activity in pancreatic acinar cells [PMID:9710595], relieving Otx2 repression by competing with Groucho co-repressors during tectal development [PMID:19736326], activating doublecortin and tyrosine hydroxylase in olfactory-bulb neurogenesis [PMID:24284204], and binding Zfp503 and Six3 promoters to specify striatal medium-spiny-neuron identity [PMID:35156680]. In limb development MEIS2 establishes proximal identity that antagonizes distal outgrowth and is spatially restricted by PRC1/RING1-mediated epigenetic repression in the distal bud, a repression axis genetically required for proximal-distal patterning [PMID:10619030, PMID:26674308, PMID:30190278]; its midbrain activation depends on a tissue-specific enhancer-promoter topological switch controlled by RING1 [PMID:24374176]. MEIS2 is essential for cranial and cardiac neural crest development, palatal and craniofacial skeletogenesis via direct regulation of osteogenic genes and SHOX2, inner ear morphogenesis, and end-organ innervation by cutaneous mechanoreceptors [PMID:26545946, PMID:32169905, PMID:32616504, PMID:34124068, PMID:38386003]. Its abundance and localization are tuned post-translationally: arginine methylation impairs CRM1-mediated nuclear export to promote neuronal differentiation [PMID:29641989], calpain-2 cleaves MEIS2 unless protected by phosphorylation or PBX1 dimerization [PMID:38305737], O-GlcNAcylation at Ser237 blocks ubiquitination to stabilize the protein [PMID:41936590], and the CRL4-cereblon E3 ligase targets MEIS2 in a manner modulated by IMiDs [PMID:30975979]. In disease contexts MEIS2 promotes neuroblastoma mitotic progression through FOXM1 [PMID:25210800] and collaborates with AML1-ETO leukemogenesis [PMID:27346355].","teleology":[{"year":1998,"claim":"Established that MEIS2 is not a solitary DNA-binding factor but a combinatorial partner that reprograms the activity of a co-bound homeodomain protein, defining its mechanistic mode of action.","evidence":"Co-IP, EMSA, and reporter assays on the pancreatic elastase I enhancer in acinar versus beta-cell lines","pmids":["9710595"],"confidence":"High","gaps":["Did not define MEIS2's intrinsic activation/repression contribution separate from PDX1/PBX1","Restricted to pancreatic acinar context"]},{"year":1999,"claim":"Placed MEIS2 in a developmental patterning role, showing it confers proximal limb identity and antagonizes distal outgrowth downstream of BMP and Hox cues.","evidence":"Retroviral misexpression in chick limb buds with distal-marker readouts and BMP/Hoxd epistasis","pmids":["10619030"],"confidence":"High","gaps":["Gain-of-function only; endogenous requirement not tested here","Direct target genes in limb not identified"]},{"year":2000,"claim":"Defined MEIS2 as a direct, sequence-specific transcriptional activator and revealed that splice variants and competitor TGIF modulate this activity, including a dominant-negative isoform.","evidence":"EMSA, luciferase reporters across isoforms, and dominant-negative overexpression on the dopamine D1A receptor promoter","pmids":["10764806"],"confidence":"High","gaps":["Physiological roles of individual isoforms not established","TGIF competition not validated in vivo"]},{"year":2010,"claim":"Resolved the molecular basis of MEIS2 transcriptional control by showing the Hth domain autoinhibits the activation domain and PBX1 binding relieves it.","evidence":"Domain deletion/fusion constructs, Gal4 activation assays, and Co-IP for Pbx1 interaction","pmids":["20553494"],"confidence":"High","gaps":["Structural mechanism of autoinhibition not solved","Whether all partner complexes relieve autoinhibition similarly unknown"]},{"year":2009,"claim":"Showed MEIS2 can act by relieving repression—competing with a Groucho co-repressor for Otx2—broadening its mechanistic repertoire beyond direct activation.","evidence":"Reciprocal Co-IP, Otx2-dependent reporter, and in ovo electroporation in chick mesencephalon","pmids":["19736326"],"confidence":"High","gaps":["Direct target genes downstream of Otx2 derepression not mapped","Single developmental context"]},{"year":2013,"claim":"Identified MEIS2 as a cell-autonomous driver of adult SVZ neurogenesis and named its first direct neuronal targets, linking the factor to dopaminergic neuron generation.","evidence":"Co-IP for a Meis2-Pax6-Dlx2 complex, ChIP for doublecortin/TH targets, and retroviral loss-of-function in vivo","pmids":["24284204"],"confidence":"High","gaps":["Genome-wide target set not defined here","Stoichiometry of the tripartite complex unknown"]},{"year":2013,"claim":"Revealed how MEIS2 itself is transcriptionally controlled by a RING1-dependent enhancer-promoter topological switch during midbrain activation.","evidence":"ChIP, 3C chromatin conformation capture, and Ring1B conditional knockout mouse","pmids":["24374176"],"confidence":"High","gaps":["Factors triggering RBS dissociation unknown","Generality of the topological switch to other tissues untested"]},{"year":2015,"claim":"Established a genetic PRC1-MEIS2 repression axis required for proximal-distal limb specification, with RA-related signals competing to polarize Meis2 expression.","evidence":"Ring1A/B and PCGF3/5 conditional knockouts, Meis2 compound-mutant rescue, ChIP, and RA pathway epistasis","pmids":["26674308","30190278"],"confidence":"High","gaps":["Direct PRC1 recruitment mechanism at the Meis2 locus incompletely defined","Quantitative threshold of Meis2 derepression needed for distal defects unclear"]},{"year":2015,"claim":"Demonstrated an essential requirement for MEIS2 in neural crest derivatives, with loss causing craniofacial, cardiac outflow, and cranial nerve defects and systemic loss being embryonic-lethal.","evidence":"AP2α-IRES-Cre and systemic Meis2 knockout mice with histology and immunofluorescence","pmids":["26545946"],"confidence":"High","gaps":["Direct neural-crest target genes not identified in this study","Cause of embryonic lethality/hemorrhage not mechanistically resolved"]},{"year":2020,"claim":"Provided genome-wide direct target maps in palatal neural crest, identifying SHOX2 as both partner and target and tying MEIS2 to osteogenic gene regulation and Shh-dependent arch patterning.","evidence":"ChIP-seq, ATAC-seq, RNA-seq, Co-IP, and Wnt1-Cre conditional knockouts with palatal/arch phenotypes","pmids":["32169905","32616504"],"confidence":"High","gaps":["Whether MEIS2-SHOX2 co-occupancy is direct cooperative binding at all sites unresolved","Link between Shh loss and downstream ossification incompletely mapped"]},{"year":2022,"claim":"Defined MEIS2's role in striatal MSN fate, showing it acts downstream of Dlx1/2 via enhancer hs599 and directly binds Zfp503 and Six3 to specify D1/D2 neuron identity.","evidence":"Meis2 conditional knockout, ChIP for direct promoter binding, and Dlx1/2 epistasis","pmids":["35156680"],"confidence":"High","gaps":["How a single factor selects D1 versus D2 programs not resolved","Cofactors at Zfp503/Six3 promoters not defined"]},{"year":2021,"claim":"Extended MEIS2's organogenesis roles to inner ear formation and cochlear duct coiling with tissue-specific direct candidate targets.","evidence":"Hindbrain- and inner-ear-specific conditional knockouts, RNA-seq, and ChIP-seq in an otic cell line","pmids":["34124068"],"confidence":"High","gaps":["Functional validation of individual otic targets pending","Cell-autonomous versus hindbrain-relayed requirement partially separated"]},{"year":2024,"claim":"Showed MEIS2 governs cutaneous mechanoreceptor maturation, controlling end-organ innervation, electrophysiology, and touch behavior without affecting neuron survival.","evidence":"LTMR-specific conditional knockouts with electrophysiology, behavior, morphology, and RNA-seq","pmids":["38386003"],"confidence":"High","gaps":["Direct transcriptional targets driving innervation morphology not identified","Target-derived signal controlling Meis2 expression unknown"]},{"year":2018,"claim":"Identified arginine methylation as a post-translational switch that retains MEIS2 in the nucleus by blocking CRM1 export, coupling the PTM to neuronal differentiation.","evidence":"Site-directed methylation mutagenesis, Co-IP of CRM1/PBX1, and subcellular fractionation in SVZ progenitors","pmids":["29641989"],"confidence":"High","gaps":["Methyltransferase responsible not identified","Whether methylation alters DNA binding or only localization unclear"]},{"year":2024,"claim":"Established calpain-2 proteolysis as a determinant of MEIS2 full-length stability during neurogenesis, with phosphorylation or PBX1 dimerization protecting against cleavage.","evidence":"Reconstituted in vitro cleavage assay, phospho-site mutagenesis, Co-IP, and calpain-2 manipulation in V-SVZ progenitors","pmids":["38305737"],"confidence":"High","gaps":["Cleavage products' fate and any function not characterized","Kinase mediating protective phosphorylation not identified"]},{"year":2026,"claim":"Showed O-GlcNAcylation at Ser237 stabilizes MEIS2 by blocking ubiquitination, linking nutrient-sensing glycosylation to palatal osteogenic homeostasis.","evidence":"O-GlcNAc-IP, Ser237 mutagenesis, ubiquitination assays, and zebrafish OGT loss-of-function","pmids":["41936590"],"confidence":"Medium","gaps":["E3 ligase opposing this PTM in palate not identified","Crosstalk with calpain and CRBN pathways untested"]},{"year":2019,"claim":"Identified MEIS2 as a cereblon (CRL4-CRBN) substrate whose IMiD-blockable binding links it to therapeutic E3-ligase modulation and Cyclin E regulation in myeloma.","evidence":"Crystal-structure substrate identification, RNAi knockdown, and viability/apoptosis assays","pmids":["30975979"],"confidence":"Medium","gaps":["In vivo physiological role of CRBN-mediated MEIS2 turnover unknown","Degron determinants on MEIS2 not fully mapped"]},{"year":2014,"claim":"Connected MEIS2 to mitotic gene control in cancer, showing it activates the MuvB-BMYB-FOXM1 program with FOXM1 as a direct target required for neuroblastoma survival.","evidence":"siRNA/overexpression with M-phase readouts, ChIP for FOXM1, and rescue experiments","pmids":["25210800"],"confidence":"High","gaps":["Whether the FOXM1 axis operates in normal proliferating cells unclear","Upstream control of MEIS2 in neuroblastoma not defined"]},{"year":2016,"claim":"Showed MEIS2 binds the AML1-ETO Runt domain and collaborates in leukemogenesis by relieving AML1-ETO repressive DNA binding and inducing YES1.","evidence":"Co-IP of the Runt-domain interaction, shRNA knockdown in AML lines, and a murine leukemia model","pmids":["27346355"],"confidence":"Medium","gaps":["Direct MEIS2 binding sites genome-wide in AML not mapped","Single lab; reciprocal validation limited"]},{"year":2025,"claim":"Extended the MEIS2-CRBN axis to show CDK4/6 inhibition accelerates IMiD-driven MEIS2 displacement and destabilization, enhancing IKZF degradation and modulating BCMA in myeloma.","evidence":"Biochemical displacement and ubiquitination assays with ex vivo primary myeloma cells (preprint)","pmids":["41279046"],"confidence":"Medium","gaps":["Preprint, not yet peer-reviewed","Mechanism by which CDK4/6 inhibition raises CRBN unresolved"]},{"year":null,"claim":"How alternative splicing generates functionally distinct MEIS2 isoforms with different transcriptional targets across cell-state transitions remains incompletely defined.","evidence":"Open question integrating isoform-specific functions (e.g., Rbfox-driven progenitor-to-neuron switch and PTBP1/MEIS2-L in cancer)","pmids":[],"confidence":"Medium","gaps":["Full target repertoires of distinct isoforms unmapped","Whether PTM regulation differs between isoforms unknown","In vivo phenotypic consequences of isoform balance largely untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,5,7,9,23]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,7,20,23]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[14]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[8,20,23]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2,7,23]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,11,20,22,25]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[8,10,15]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[5,9,19]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[14,18,24,26]}],"complexes":["MEIS2-PBX1-PDX1 trimeric complex","MEIS2-Pax6-Dlx2 complex","CRL4-cereblon (CRBN) E3 ubiquitin ligase (as substrate)"],"partners":["PBX1","PDX1","PAX6","DLX2","OTX2","KLF4","SHOX2","CRM1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O14770","full_name":"Homeobox protein Meis2","aliases":["Meis1-related protein 1"],"length_aa":477,"mass_kda":51.8,"function":"Involved in transcriptional regulation. Binds to HOX or PBX proteins to form dimers, or to a DNA-bound dimer of PBX and HOX proteins and thought to have a role in stabilization of the homeoprotein-DNA complex. Isoform 3 is required for the activity of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element; MEIS2 is not involved in complex DNA-binding. Probably in complex with PBX1, is involved in transcriptional regulation by KLF4. Isoform 3 and isoform 4 can bind to a EPHA8 promoter sequence containing the DNA motif 5'-CGGTCA-3'; in cooperation with a PBX protein (such as PBX2) is proposed to be involved in the transcriptional activation of EPHA8 in the developing midbrain. May be involved in regulation of myeloid differentiation. Can bind to the DNA sequence 5'-TGACAG-3'in the activator ACT sequence of the D(1A) dopamine receptor (DRD1) promoter and activate DRD1 transcription; isoform 5 cannot activate DRD1 transcription","subcellular_location":"Nucleus; Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/O14770/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MEIS2","classification":"Not Classified","n_dependent_lines":14,"n_total_lines":1208,"dependency_fraction":0.011589403973509934},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MEIS2","total_profiled":1310},"omim":[{"mim_id":"618365","title":"ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 10; ZSCAN10","url":"https://www.omim.org/entry/618365"},{"mim_id":"616898","title":"CHROMOSOME 15q14 DELETION SYNDROME","url":"https://www.omim.org/entry/616898"},{"mim_id":"610942","title":"MICRO RNA 204; MIR204","url":"https://www.omim.org/entry/610942"},{"mim_id":"609262","title":"CEREBLON; CRBN","url":"https://www.omim.org/entry/609262"},{"mim_id":"607108","title":"PAIRED BOX GENE 6; PAX6","url":"https://www.omim.org/entry/607108"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"salivary gland","ntpm":45.2}],"url":"https://www.proteinatlas.org/search/MEIS2"},"hgnc":{"alias_symbol":["MRG1","HsT18361"],"prev_symbol":[]},"alphafold":{"accession":"O14770","domains":[{"cath_id":"1.10.10.60","chopping":"284-347","consensus_level":"high","plddt":90.9142,"start":284,"end":347},{"cath_id":"1.20.58","chopping":"68-184","consensus_level":"high","plddt":85.1072,"start":68,"end":184}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O14770","model_url":"https://alphafold.ebi.ac.uk/files/AF-O14770-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O14770-F1-predicted_aligned_error_v6.png","plddt_mean":61.97},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MEIS2","jax_strain_url":"https://www.jax.org/strain/search?query=MEIS2"},"sequence":{"accession":"O14770","fasta_url":"https://rest.uniprot.org/uniprotkb/O14770.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O14770/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O14770"}},"corpus_meta":[{"pmid":"10619030","id":"PMC_10619030","title":"Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal antagonism of BMPs by Gremlin.","date":"1999","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/10619030","citation_count":251,"is_preprint":false},{"pmid":"20713703","id":"PMC_20713703","title":"miR-204 is required for lens and retinal development via Meis2 targeting.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20713703","citation_count":157,"is_preprint":false},{"pmid":"9710595","id":"PMC_9710595","title":"An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2).","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9710595","citation_count":146,"is_preprint":false},{"pmid":"26545946","id":"PMC_26545946","title":"Meis2 is essential for cranial and cardiac neural crest development.","date":"2015","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26545946","citation_count":107,"is_preprint":false},{"pmid":"24284204","id":"PMC_24284204","title":"Meis2 is a Pax6 co-factor in neurogenesis and dopaminergic periglomerular fate specification in the adult olfactory bulb.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24284204","citation_count":97,"is_preprint":false},{"pmid":"24374176","id":"PMC_24374176","title":"Polycomb potentiates meis2 activation in midbrain by mediating interaction of the promoter with a tissue-specific enhancer.","date":"2013","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/24374176","citation_count":95,"is_preprint":false},{"pmid":"30742945","id":"PMC_30742945","title":"Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.","date":"2019","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/30742945","citation_count":86,"is_preprint":false},{"pmid":"9337137","id":"PMC_9337137","title":"Meis2, a novel mouse Pbx-related homeobox gene induced by retinoic acid during differentiation of P19 embryonal carcinoma cells.","date":"1997","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9337137","citation_count":84,"is_preprint":false},{"pmid":"10764806","id":"PMC_10764806","title":"Three-amino acid extension loop homeodomain proteins Meis2 and TGIF differentially regulate transcription.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10764806","citation_count":70,"is_preprint":false},{"pmid":"19736326","id":"PMC_19736326","title":"Meis2 competes with the Groucho co-repressor Tle4 for binding to Otx2 and specifies tectal fate without induction of a secondary midbrain-hindbrain boundary organizer.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19736326","citation_count":68,"is_preprint":false},{"pmid":"29716922","id":"PMC_29716922","title":"MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.","date":"2018","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/29716922","citation_count":62,"is_preprint":false},{"pmid":"31315484","id":"PMC_31315484","title":"Inhibition of Senescence-Associated Genes Rb1 and Meis2 in Adult Cardiomyocytes Results in Cell Cycle Reentry and Cardiac Repair Post-Myocardial Infarction.","date":"2019","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/31315484","citation_count":60,"is_preprint":false},{"pmid":"18461604","id":"PMC_18461604","title":"Expression of FOXP2 in the developing monkey forebrain: comparison with the expression of the genes FOXP1, PBX3, and MEIS2.","date":"2008","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18461604","citation_count":59,"is_preprint":false},{"pmid":"9337138","id":"PMC_9337138","title":"Expression of Meis2, a Knotted-related murine homeobox gene, indicates a role in the differentiation of the forebrain and the somitic mesoderm.","date":"1997","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9337138","citation_count":58,"is_preprint":false},{"pmid":"28041912","id":"PMC_28041912","title":"A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28041912","citation_count":56,"is_preprint":false},{"pmid":"25210800","id":"PMC_25210800","title":"MEIS2 is essential for neuroblastoma cell survival and proliferation by transcriptional control of M-phase progression.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25210800","citation_count":51,"is_preprint":false},{"pmid":"25712757","id":"PMC_25712757","title":"MEIS2 involvement in cardiac development, cleft palate, and intellectual disability.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25712757","citation_count":50,"is_preprint":false},{"pmid":"22390724","id":"PMC_22390724","title":"Genetic and physical interaction of Meis2, Pax3 and Pax7 during dorsal midbrain development.","date":"2012","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22390724","citation_count":46,"is_preprint":false},{"pmid":"23541832","id":"PMC_23541832","title":"FOXC1 in human trabecular meshwork cells is involved in regulatory pathway that includes miR-204, MEIS2, and ITGβ1.","date":"2013","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/23541832","citation_count":43,"is_preprint":false},{"pmid":"21746878","id":"PMC_21746878","title":"Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21746878","citation_count":42,"is_preprint":false},{"pmid":"27346355","id":"PMC_27346355","title":"MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27346355","citation_count":40,"is_preprint":false},{"pmid":"24678003","id":"PMC_24678003","title":"Haploinsufficiency of MEIS2 is associated with orofacial clefting and learning disability.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/24678003","citation_count":38,"is_preprint":false},{"pmid":"30526668","id":"PMC_30526668","title":"MEIS2 regulates endothelial to hematopoietic transition of human embryonic stem cells by targeting TAL1.","date":"2018","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30526668","citation_count":36,"is_preprint":false},{"pmid":"27225850","id":"PMC_27225850","title":"De novo MEIS2 mutation causes syndromic developmental delay with persistent gastro-esophageal reflux.","date":"2016","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27225850","citation_count":34,"is_preprint":false},{"pmid":"30735726","id":"PMC_30735726","title":"MEIS2 gene is responsible for intellectual disability, cardiac defects and a distinct facial phenotype.","date":"2019","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30735726","citation_count":33,"is_preprint":false},{"pmid":"11287203","id":"PMC_11287203","title":"Cloning and developmental expression of a zebrafish meis2 homeobox gene.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11287203","citation_count":33,"is_preprint":false},{"pmid":"30291340","id":"PMC_30291340","title":"Heterozygous loss-of-function variants of MEIS2 cause a triad of palatal defects, congenital heart defects, and intellectual disability.","date":"2018","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/30291340","citation_count":33,"is_preprint":false},{"pmid":"30859572","id":"PMC_30859572","title":"Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30859572","citation_count":32,"is_preprint":false},{"pmid":"35156680","id":"PMC_35156680","title":"Dlx1/2-dependent expression of Meis2 promotes neuronal fate determination in the mammalian striatum.","date":"2022","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35156680","citation_count":31,"is_preprint":false},{"pmid":"17729288","id":"PMC_17729288","title":"Expression of the homeodomain transcription factor Meis2 in the embryonic and postnatal retina.","date":"2007","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17729288","citation_count":29,"is_preprint":false},{"pmid":"20523026","id":"PMC_20523026","title":"Spatiotemporal distribution of PAX6 and MEIS2 expression and total cell numbers in the ganglionic eminence in the early developing human forebrain.","date":"2010","source":"Developmental neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20523026","citation_count":29,"is_preprint":false},{"pmid":"30055086","id":"PMC_30055086","title":"De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30055086","citation_count":29,"is_preprint":false},{"pmid":"26512644","id":"PMC_26512644","title":"miR-134 Modulates the Proliferation of Human Cardiomyocyte Progenitor Cells by Targeting Meis2.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26512644","citation_count":27,"is_preprint":false},{"pmid":"31115559","id":"PMC_31115559","title":"MEIS2 promotes cell migration and invasion in colorectal cancer.","date":"2019","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/31115559","citation_count":25,"is_preprint":false},{"pmid":"32169905","id":"PMC_32169905","title":"The transcriptional regulator MEIS2 sets up the ground state for palatal osteogenesis in mice.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32169905","citation_count":22,"is_preprint":false},{"pmid":"36113831","id":"PMC_36113831","title":"IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.","date":"2022","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36113831","citation_count":22,"is_preprint":false},{"pmid":"28960191","id":"PMC_28960191","title":"Meis2 as a critical player in MN1-induced leukemia.","date":"2017","source":"Blood cancer journal","url":"https://pubmed.ncbi.nlm.nih.gov/28960191","citation_count":21,"is_preprint":false},{"pmid":"34638267","id":"PMC_34638267","title":"MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34638267","citation_count":21,"is_preprint":false},{"pmid":"32616504","id":"PMC_32616504","title":"Neural crest cells require Meis2 for patterning the mandibular arch via the Sonic hedgehog pathway.","date":"2020","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/32616504","citation_count":19,"is_preprint":false},{"pmid":"20553494","id":"PMC_20553494","title":"An autoinhibitory effect of the homothorax domain of Meis2.","date":"2010","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/20553494","citation_count":19,"is_preprint":false},{"pmid":"25166052","id":"PMC_25166052","title":"Differential expression of Meis2, Mab21l2 and Tbx3 during limb development associated with diversification of limb morphology in mammals.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25166052","citation_count":18,"is_preprint":false},{"pmid":"11731263","id":"PMC_11731263","title":"Cloning and expression of the TALE superclass homeobox Meis2 gene during zebrafish embryonic development.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11731263","citation_count":17,"is_preprint":false},{"pmid":"36840946","id":"PMC_36840946","title":"CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis.","date":"2023","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/36840946","citation_count":16,"is_preprint":false},{"pmid":"29641989","id":"PMC_29641989","title":"Arginine Methylation Regulates MEIS2 Nuclear Localization to Promote Neuronal Differentiation of Adult SVZ Progenitors.","date":"2018","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29641989","citation_count":16,"is_preprint":false},{"pmid":"33975520","id":"PMC_33975520","title":"Meis homeobox 2 (MEIS2) inhibits the proliferation and promotes apoptosis of thyroid cancer cell and through the NF-κB signaling pathway.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/33975520","citation_count":15,"is_preprint":false},{"pmid":"30975979","id":"PMC_30975979","title":"The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30975979","citation_count":15,"is_preprint":false},{"pmid":"30190278","id":"PMC_30190278","title":"Variant PRC1 competes with retinoic acid-related signals to repress Meis2 in the mouse distal forelimb bud.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30190278","citation_count":15,"is_preprint":false},{"pmid":"34053876","id":"PMC_34053876","title":"LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628-5p/MEIS2 axis to activate the Notch pathway.","date":"2021","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/34053876","citation_count":14,"is_preprint":false},{"pmid":"26674308","id":"PMC_26674308","title":"RING1 proteins contribute to early proximal-distal specification of the forelimb bud by restricting Meis2 expression.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26674308","citation_count":14,"is_preprint":false},{"pmid":"31640805","id":"PMC_31640805","title":"Epigenetic silencing of MEIS2 in prostate cancer recurrence.","date":"2019","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/31640805","citation_count":12,"is_preprint":false},{"pmid":"35416122","id":"PMC_35416122","title":"MicroRNA-18 facilitates the stemness of gastric cancer by downregulating HMGB3 though targeting Meis2.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35416122","citation_count":12,"is_preprint":false},{"pmid":"34124068","id":"PMC_34124068","title":"Meis2 Is Required for Inner Ear Formation and Proper Morphogenesis of the Cochlea.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34124068","citation_count":10,"is_preprint":false},{"pmid":"25861444","id":"PMC_25861444","title":"Retinoic acid-independent expression of Meis2 during autopod patterning in the developing bat and mouse limb.","date":"2015","source":"EvoDevo","url":"https://pubmed.ncbi.nlm.nih.gov/25861444","citation_count":10,"is_preprint":false},{"pmid":"33427397","id":"PMC_33427397","title":"Intellectual disability associated with craniofacial dysmorphism, cleft palate, and congenital heart defect due to a de novo MEIS2 mutation: A clinical longitudinal study.","date":"2021","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/33427397","citation_count":9,"is_preprint":false},{"pmid":"26221261","id":"PMC_26221261","title":"Depletion of MEIS2 inhibits osteogenic differentiation potential of human dental stem cells.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26221261","citation_count":8,"is_preprint":false},{"pmid":"38386003","id":"PMC_38386003","title":"Touch receptor end-organ innervation and function require sensory neuron expression of the transcription factor Meis2.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/38386003","citation_count":7,"is_preprint":false},{"pmid":"33091211","id":"PMC_33091211","title":"MEIS2 sequence variant in a child with intellectual disability and cardiac defects: Expansion of the phenotypic spectrum and documentation of low-level mosaicism in an unaffected parent.","date":"2020","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/33091211","citation_count":7,"is_preprint":false},{"pmid":"33722742","id":"PMC_33722742","title":"A novel MEIS2 mutation explains the complex phenotype in a boy with a typical NF1 microdeletion syndrome.","date":"2021","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33722742","citation_count":7,"is_preprint":false},{"pmid":"36753664","id":"PMC_36753664","title":"ERN1 dependent impact of glucose and glutamine deprivations on PBX3, PBXIP1, PAX6, MEIS1, and MEIS2 genes expression in U87 glioma cells.","date":"2023","source":"Endocrine regulations","url":"https://pubmed.ncbi.nlm.nih.gov/36753664","citation_count":6,"is_preprint":false},{"pmid":"30594396","id":"PMC_30594396","title":"Meis2 represses the osteoblastic transdifferentiation of aortic valve interstitial cells through the Notch1/Twist1 pathway.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30594396","citation_count":6,"is_preprint":false},{"pmid":"38711262","id":"PMC_38711262","title":"MEIS2 suppresses breast cancer development by downregulating IL10.","date":"2024","source":"Cancer reports (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/38711262","citation_count":5,"is_preprint":false},{"pmid":"37660994","id":"PMC_37660994","title":"LINC-PINT suppresses breast cancer cell proliferation and migration via MEIS2/PPP3CC/NF-κB pathway by sponging miR-576-5p.","date":"2023","source":"The American journal of the medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37660994","citation_count":5,"is_preprint":false},{"pmid":"36418415","id":"PMC_36418415","title":"The autism-associated Meis2 gene is necessary for cardiac baroreflex regulation in mice.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36418415","citation_count":5,"is_preprint":false},{"pmid":"38305737","id":"PMC_38305737","title":"The neuronal transcription factor MEIS2 is a calpain-2 protease target.","date":"2024","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/38305737","citation_count":4,"is_preprint":false},{"pmid":"40252346","id":"PMC_40252346","title":"LncRNA RMG controls liquid-liquid phase separation of MEIS2 to regulate myogenesis.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40252346","citation_count":4,"is_preprint":false},{"pmid":"36247013","id":"PMC_36247013","title":"Meis2 controls skeletal formation in the hyoid region.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36247013","citation_count":4,"is_preprint":false},{"pmid":"34930369","id":"PMC_34930369","title":"MEIS2 (15q14) gene deletions in siblings with mild developmental phenotypes and bifid uvula: documentation of mosaicism in an unaffected parent.","date":"2021","source":"Molecular cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/34930369","citation_count":4,"is_preprint":false},{"pmid":"19188860","id":"PMC_19188860","title":"Sonic hedgehog signaling in the chick retina accelerates Meis2 downregulation simultaneously with retinal ganglion cell genesis.","date":"2009","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/19188860","citation_count":4,"is_preprint":false},{"pmid":"39351969","id":"PMC_39351969","title":"Analysis of Meis2 knockout mice reveals Sonic hedgehog-mediated patterning of the cochlear duct.","date":"2024","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/39351969","citation_count":2,"is_preprint":false},{"pmid":"40183774","id":"PMC_40183774","title":"Mesenchymal Meis2 controls whisker development independently from trigeminal sensory innervation.","date":"2025","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/40183774","citation_count":2,"is_preprint":false},{"pmid":"40249092","id":"PMC_40249092","title":"High-Grade Uterine Sarcoma: First Report of a MEIS2::FOXO4 Fusion.","date":"2025","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40249092","citation_count":1,"is_preprint":false},{"pmid":"41313264","id":"PMC_41313264","title":"Comparative distribution of the hypothalamic neurons activated during wakefulness and paradoxical (REM) sleep using male TRAP2-red mice: contribution of orexin, MCH, Lhx6, and a new marker Meis2.","date":"2026","source":"Sleep","url":"https://pubmed.ncbi.nlm.nih.gov/41313264","citation_count":1,"is_preprint":false},{"pmid":"39789493","id":"PMC_39789493","title":"Long read Nanopore sequencing identifies precise breakpoints of a de novo paracentric inversion that disrupt the MEIS2 gene in a Chinese girl with syndromic developmental delay.","date":"2025","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/39789493","citation_count":1,"is_preprint":false},{"pmid":"32138576","id":"PMC_32138576","title":"Placental Expression of the Forelimb Patterning Transcription Factor MEIS2 in Trisomy 15.","date":"2020","source":"Fetal and pediatric pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32138576","citation_count":0,"is_preprint":false},{"pmid":"39639090","id":"PMC_39639090","title":"Multi-omics analysis detail a submicroscopic inv(15)(q14q15) generating fusion transcripts and MEIS2 and NUSAP1 haploinsufficiency.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39639090","citation_count":0,"is_preprint":false},{"pmid":"41031828","id":"PMC_41031828","title":"MEIS2 Modulates Oxidative Phosphorylation and ROS Generation to Affect CD8+ T Cell Antitumor Immunity in Prostate Cancer.","date":"2025","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/41031828","citation_count":0,"is_preprint":false},{"pmid":"41280242","id":"PMC_41280242","title":"Developmental and adult expression of the Meis2 transcription factor in the central nervous system of Xenopus laevis: a developmental and evolutive analysis.","date":"2025","source":"Frontiers in neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/41280242","citation_count":0,"is_preprint":false},{"pmid":"42000104","id":"PMC_42000104","title":"Meis1 and Meis2 are jointly required for advanced stages of mouse lens morphogenesis.","date":"2026","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/42000104","citation_count":0,"is_preprint":false},{"pmid":"41080700","id":"PMC_41080700","title":"Functional analysis of MEIS2 splice site variant c.438 + 1G>T in a congenital heart patient.","date":"2025","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41080700","citation_count":0,"is_preprint":false},{"pmid":"39776641","id":"PMC_39776641","title":"Cleft palate, congenital heart disease, and developmental delay involving MEIS2 heterozygous mutations found in the patient with attention deficit hyperactivity disorder: a case report.","date":"2024","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/39776641","citation_count":0,"is_preprint":false},{"pmid":"41936590","id":"PMC_41936590","title":"OGT mediates O-GlcNAcylation of MEIS2 and affects palatal osteogenic development.","date":"2026","source":"International journal of oral science","url":"https://pubmed.ncbi.nlm.nih.gov/41936590","citation_count":0,"is_preprint":false},{"pmid":"41279046","id":"PMC_41279046","title":"CDK4/6 Inhibition Reverses MEIS2 Suppression of CRL4 CRBN to Enhance Immunomodulatory Drug Therapy in Multiple Myeloma.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41279046","citation_count":0,"is_preprint":false},{"pmid":"42073401","id":"PMC_42073401","title":"Development of Chitosan-Carbon Dot Hybrid Nanoemulsomes for MEIS2 Inhibitor Delivery and Bioimaging in Colorectal Cancer.","date":"2026","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/42073401","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.14.681840","title":"CDK4/6 Inhibition Reverses MEIS2 Suppression of CRL4  <sup>CRBN</sup>  to Enhance Immunomodulatory Drug Therapy in Multiple Myeloma","date":"2025-10-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.14.681840","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.22.677817","title":"Calpain-2 inhibition or deletion enhances levels of the transcription Factor, MEIS2, and stimulates neurogenesis","date":"2025-09-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.22.677817","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.17.676258","title":"Comparative distribution of the hypothalamic neurons activated during Wakefulness and Paradoxical (REM) sleep using TRAP2-red mice: contribution of Orexin, MCH, Lhx6 and a new marker Meis2","date":"2025-09-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.17.676258","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.11.687613","title":"WNT inhibition primes the transcriptional landscape of mesoderm to initiate a phased ventricular cardiomyocyte specification programme","date":"2025-11-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.11.687613","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.01.651492","title":"Overexpression of Meis factors in late-stage retinal progenitors yields complex effects on temporal patterning and neurogenesis","date":"2025-05-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.01.651492","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.19.689260","title":"Canopy1/Cnpy1 is required for proper V2R processing and transport; its loss impairs the function and circuit organization of basal/V2R vomeronasal sensory neurons","date":"2025-11-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.19.689260","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.09.687497","title":"Hox-Meis-relayed gene regulatory transition underlies cardiopharyngeal neural crest diversification","date":"2025-11-11","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.09.687497","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.12.628232","title":"<i>MCM2</i>  mediates post-MI cardioprotection by promoting the pro-angiogenic cardiosome signaling","date":"2024-12-17","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.12.628232","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.05.651905","title":"Integrative Single-Cell Analysis of Autism Spectrum Disorder Animal Models Reveal Convergent Transcriptomic Dysregulation Involved in Excitatory-Inhibitory Imbalance and Glial Disfunction","date":"2025-05-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.05.651905","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.05.674487","title":"Insulin resistance alters cortical inhibitory neurons and microglia to exacerbate Alzheimer’s knock-in mouse phenotypes","date":"2025-09-11","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.05.674487","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.30.679475","title":"Brain injury reactivates a developmental program driving genesis and integration of transient LGE-class interneurons","date":"2025-10-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.30.679475","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.10.617585","title":"Comparative single-cell analyses reveal evolutionary repurposing of a conserved gene program in bat wing development","date":"2024-10-13","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.10.617585","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.03.25323233","title":"Distinguishing syndromic and nonsyndromic cleft palate through analysis of protein-altering de novo variants in 816 trios","date":"2025-03-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.03.25323233","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.09.612108","title":"Cell-type-specific splicing of transcription regulators and  <i>Ptbp1</i>  by  <i>Rbfox1/2/3</i>  in the developing neocortex","date":"2024-09-10","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.09.612108","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.24.605021","title":"<i>Mitf</i>  over-expression leads to microphthalmia and coloboma in  <i>Mitf-cre</i>  mice","date":"2024-07-25","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.24.605021","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.20.644433","title":"A structure-guided approach to non-coding variant evaluation for transcription factor binding using AlphaFold 3","date":"2025-03-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.20.644433","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.24.644862","title":"Genome-wide association studies reveal novel loci associated with carcass and body measures in goats (  <i>Capra hircus</i>  )","date":"2025-03-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.24.644862","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51546,"output_tokens":7902,"usd":0.136584,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17269,"output_tokens":6164,"usd":0.120222,"stage2_stop_reason":"end_turn"},"total_usd":0.256806,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"MEIS2 (MRG1) forms a trimeric complex with PBX1b and PDX1 on the B element of the pancreatic elastase I gene enhancer in acinar cells, switching PDX1 transcriptional activity from beta-cell-type activation to acinar-cell-type activity dependent on other enhancer elements; beta-cell lines lack PBX1b and MRG1/MEIS2, preventing trimeric complex formation.\",\n      \"method\": \"Co-immunoprecipitation, electrophoretic mobility shift assay, transcriptional reporter assays in acinar and beta-cell lines, B element mutagenesis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (Co-IP, EMSA, reporter assays, mutagenesis) in a single rigorous study establishing trimeric complex and functional consequence\",\n      \"pmids\": [\"9710595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Ectopic Meis2 expression in the chick limb bud severely disrupts distal limb outgrowth and represses distal genes; Meis2 is normally restricted to proximal regions by BMPs and Hoxd genes, establishing a proximal identity that antagonizes distal outgrowth.\",\n      \"method\": \"Retroviral misexpression in chick limb buds, in situ hybridization for distal markers, epistasis with BMP and Hoxd gene manipulations\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function misexpression with defined phenotypic readout and epistasis, replicated across multiple gene combinations\",\n      \"pmids\": [\"10619030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Meis2 isoforms (a-d) bind the ACT activator sequence of the dopamine D1A receptor gene promoter and activate transcription; TGIF competes with Meis2 for binding to this site and represses Meis2-induced activation. Splice variant Meis2e, with a truncated homeodomain, cannot bind DNA or activate transcription but acts as a dominant-negative inhibitor of Meis2d-induced transcription.\",\n      \"method\": \"EMSA (DNA binding assay), luciferase transcriptional reporter assays in multiple cell types, dominant-negative overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct DNA-binding assays combined with reporter assays and dominant-negative mutagenesis, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"10764806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Meis2 physically interacts with Otx2 and competes with the Groucho co-repressor Tle4 (Grg4) for binding to Otx2, thereby relieving Otx2 transcriptional repression and restoring its activator function during tectal development in chick.\",\n      \"method\": \"Co-immunoprecipitation, Otx2-dependent reporter assay, in ovo electroporation gain- and loss-of-function in chick mesencephalic vesicle\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP demonstrating direct interaction, reporter assay demonstrating functional consequence, and in vivo electroporation phenotype, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"19736326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The homothorax (Hth) domain of Meis2 autoinhibits its C-terminal transcriptional activation domain; this autoinhibition is partially relieved by Pbx1 binding to the Hth domain. A splice variant equivalent to Meis3.2 that disrupts the Hth domain derepresses the activation domain and weakens Pbx1 interaction.\",\n      \"method\": \"Transcriptional reporter assays, domain deletion and fusion constructs, Gal4-based activation domain assays, co-immunoprecipitation for Pbx1 interaction\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple deletion/fusion constructs with reporter assays and Co-IP demonstrating autoinhibition mechanism, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"20553494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Meis2 interacts with Klf4 and Pbx1 to cooperatively activate transcription of p15(Ink4a) and E-cadherin; Meis2d transcriptional activation domain is required for this cooperative activation, and reducing endogenous Meis2 or Pbx1 decreases p15 expression and increases S-phase entry.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assays, ChIP, siRNA knockdown of endogenous Meis2/Pbx1 with cell cycle readout, promoter mutagenesis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, reporter assays, ChIP, and functional knockdown with cell-cycle phenotype, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21746878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Meis2 physically interacts with Pax3 and Pax7 in the tectal anlage; Meis2 acts downstream of Pax3/Pax7 and requires balanced expression of both proteins, as demonstrated by in ovo electroporation in chick mesencephalic vesicle.\",\n      \"method\": \"Co-immunoprecipitation, in ovo electroporation gain- and loss-of-function, in situ hybridization\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP plus in vivo epistasis by electroporation, single lab\",\n      \"pmids\": [\"22390724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Meis2 forms a biochemical complex with Pax6 and Dlx2 in the olfactory bulb neurogenic system; ChIP identified doublecortin and tyrosine hydroxylase as direct Meis2 target genes in newly generated neurons; Meis2 activity is cell-autonomously required for neuronal fate acquisition by SVZ progenitors and for generation of dopaminergic periglomerular neurons.\",\n      \"method\": \"Co-immunoprecipitation (Meis2-Pax6-Dlx2 complex), chromatin immunoprecipitation (doublecortin and TH as direct targets), retroviral dominant-negative and siRNA knockdown in vivo and in vitro\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, ChIP, and retroviral loss-of-function with defined cellular phenotype, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"24284204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Polycomb RING1B binds the Meis2 promoter and a 3'-end RING1B-binding site (RBS) to repress Meis2; during early midbrain development, a midbrain-specific enhancer (MBE) forms a tripartite interaction with the promoter and RBS in a RING1-dependent manner, and subsequent dissociation of the RBS allows promoter-MBE engagement to activate Meis2 expression.\",\n      \"method\": \"ChIP, 3C/chromatin conformation capture, Ring1B conditional knockout mouse, in situ hybridization\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and 3C demonstrating tripartite interaction, genetic knockout model, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"24374176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MEIS2 is required for neuroblastoma cell survival and M-phase progression; MEIS2 functions as a transcriptional activator of the MuvB-BMYB-FOXM1 complex, and FOXM1 is a direct transcriptional target of MEIS2 required for MEIS2-induced upregulation of mitotic genes.\",\n      \"method\": \"siRNA knockdown, ectopic overexpression with proliferation/tumorigenicity assays, gene expression profiling, ChIP (FOXM1 as direct target), rescue experiments\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP identifying direct target, knockdown with M-phase arrest phenotype, rescue experiments, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"25210800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RING1A and RING1B (PRC1 components) are required for repression of Meis2 (and Meis1) in the distal forelimb bud; additional deletion of Meis2 in Ring1A/B-deficient mice partially restores distal gene expression and limb formation, establishing a RING1-MEIS2 repression axis critical for proximal-distal specification.\",\n      \"method\": \"Conditional double knockout mice (Ring1A/B), Meis2 compound knockout rescue experiment, in situ hybridization, RING1B ChIP\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis (triple mutant rescue), ChIP, and in vivo phenotype, multiple orthogonal approaches\",\n      \"pmids\": [\"26674308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Conditional inactivation of Meis2 in neural crest cells (AP2α-IRES-Cre) causes defects in craniofacial skeleton (cranial bones and cartilages), persistent truncus arteriosus, and cranial nerve abnormalities; systemic Meis2 knockout results in embryonic lethality by E14 with hemorrhaging.\",\n      \"method\": \"Conditional knockout mouse (AP2α-IRES-Cre; Meis2fl/fl), systemic knockout mouse, histology, immunofluorescence\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific conditional KO with defined phenotypic readouts in neural crest-derived tissues, multiple conditional alleles used\",\n      \"pmids\": [\"26545946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MEIS2 binds directly to the Runt domain of AML1-ETO; high MEIS2 expression impairs repressive DNA binding of AML1-ETO and induces increased expression of proto-oncogene YES1; MEIS2 collaborates with AML1-ETO to induce AML in mice.\",\n      \"method\": \"Co-immunoprecipitation (MEIS2-AML1-ETO Runt domain interaction), shRNA knockdown in AML cell lines, murine leukemia model, gene expression analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP demonstrating direct binding to Runt domain, in vivo leukemia model, and functional knockdown, single lab\",\n      \"pmids\": [\"27346355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In castration-resistant prostate cancer, MEIS2 is repressed by miR-196b-3p as part of a constitutively activated feedforward circuit composed of IκBα/NF-κB(p65), miR-196b-3p, Meis2, and PPP3CC that drives stem cell transcription factor expression and tumorigenicity.\",\n      \"method\": \"miRNA target validation, luciferase reporter assay, siRNA/shRNA knockdown of circuit components, in vivo tumorigenicity assays, NF-κB reporter assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — multiple functional assays placing MEIS2 in a feedforward signaling circuit, single lab\",\n      \"pmids\": [\"28041912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MEIS2 nuclear accumulation in adult SVZ-derived progenitor cells is controlled by arginine methylation: methylation of a conserved arginine on MEIS2 (near CRM1 and PBX1 binding sites) impairs interaction with the nuclear export receptor CRM1 without affecting PBX1 dimerization, thereby allowing MEIS2 nuclear accumulation required for neuronal differentiation.\",\n      \"method\": \"Co-immunoprecipitation (CRM1 and PBX1 interactions), arginine methylation site mutagenesis, subcellular fractionation, retroviral constructs in SVZ progenitors, EGFR signaling manipulation\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — site-directed mutagenesis of PTM site, Co-IP showing differential binding, fractionation demonstrating nuclear localization consequence, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29641989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Variant PRC1 incorporating PCGF3 and PCGF5 represses Meis2 in the distal forelimb bud by antagonizing retinoic acid-related signals; PcG factors and RA-related signals compete to polarize Meis2 expression along the proximal-distal axis.\",\n      \"method\": \"Conditional knockout mice (PCGF3/5), ChIP, mathematical modeling, RA pathway manipulation, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, conditional KO mice, and epistasis with RA pathway, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"30190278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MEIS2 regulates the endothelial-to-hematopoietic transition (EHT) during hematopoietic differentiation of human embryonic stem cells; TAL1 acts as a downstream gene mediating MEIS2 function during early hematopoiesis, as deletion of MEIS2 suppresses TAL1 expression and impairs hemogenic endothelial specification.\",\n      \"method\": \"CRISPR/Cas9 MEIS2 deletion in hESCs, hematopoietic differentiation assays, whole-genome gene profiling, TAL1 rescue experiments\",\n      \"journal\": \"Stem cell research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with defined differentiation phenotype, TAL1 identified as downstream target by rescue, single lab\",\n      \"pmids\": [\"30526668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PTBP1 upregulates the MEIS2-L splice variant to promote bladder cancer cell migration and invasion; overexpression of MEIS2-L rescues the reduced migration and invasion caused by PTBP1 knockdown, and MEIS2-L is associated with increased MMP9 expression.\",\n      \"method\": \"siRNA knockdown of PTBP1, alternative splicing analysis, MEIS2-L overexpression rescue experiments, invasion and migration assays, in vivo lymph node metastasis model\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — splicing regulation demonstrated by knockdown and rescue, in vivo and in vitro functional assays, single lab\",\n      \"pmids\": [\"30742945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MEIS2 is a substrate of the CRL4-cereblon (CRBN) E3-ubiquitin ligase complex; MEIS2 was identified as a cereblon substrate by crystal structure and biochemical screen, and IMiDs can block MEIS2 from binding CRBN, facilitating CRL4CRBN-IMiD E3 ubiquitin ligase activity. MEIS2 regulates Cyclin E/CCNE1 expression and modulates IMiD activity in multiple myeloma cells.\",\n      \"method\": \"Crystal structure (biochemical identification as CRBN substrate), RNA interference knockdown, cell viability and apoptosis assays, BET inhibitor modulation of MEIS2 expression\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — crystal structure identification as CRBN substrate cited, functional knockdown with proliferation/apoptosis phenotype, single lab; full structural data in referenced prior work\",\n      \"pmids\": [\"30975979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"siRNA-mediated simultaneous knockdown of Rb1 and Meis2 in adult cardiomyocytes promotes cell cycle reentry, increases cardiomyocyte number, decreases cell size, increases mononucleated cardiomyocytes in vitro, and in vivo reduces infarct size and improves cardiac function post-myocardial infarction, implicating Meis2 as a senescence-associated cell cycle inhibitor in adult cardiomyocytes.\",\n      \"method\": \"siRNA knockdown in adult rat and human iPSC-derived cardiomyocytes, EdU/PH3/Ki67/Aurora B immunostaining, hydrogel siRNA delivery post-MI in vivo, echocardiography\",\n      \"journal\": \"Journal of the American Heart Association\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA KD with cell cycle and cardiac functional phenotypes in vitro and in vivo, single lab with multiple orthogonal proliferation markers\",\n      \"pmids\": [\"31315484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MEIS2 directly regulates key osteogenic genes in palatal neural crest cells as determined by ChIP-seq; MEIS2 physically interacts with SHOX2, and SHOX2 is a direct downstream target of MEIS2, with genome-wide MEIS2-SHOX2 co-occupancy identified by comparative ChIP-seq. Wnt1-Cre-mediated Meis2 inactivation results in secondary palate cleft and absence of palatal bones.\",\n      \"method\": \"ChIP-seq, RNA-seq, ATAC-seq, Wnt1-Cre conditional knockout mouse, Co-immunoprecipitation (MEIS2-SHOX2 physical interaction), de novo motif analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP-seq, ATAC-seq, RNA-seq, Co-IP, and conditional KO with palatal bone phenotype, multiple orthogonal methods in single study\",\n      \"pmids\": [\"32169905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Meis2 inactivation in cranial neural crest cells results in loss of Sonic hedgehog signaling in oropharyngeal epithelium and impaired patterning of the first pharyngeal arch (PA1) along lateral-medial and oral-aboral axes, leading to hypoplastic tongue and ectopic mandibular ossification.\",\n      \"method\": \"Conditional knockout mouse (Wnt1-Cre;Meis2fl/fl), in situ hybridization for Shh pathway components, expression analysis of Hand1/2, Dlx5, Barx1, Gsc\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional neural crest KO with defined Shh pathway placement and craniofacial phenotype, single lab\",\n      \"pmids\": [\"32616504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Meis2 is required for inner ear formation: hindbrain-specific Meis2 expression is essential for otic vesicle formation, and inner-ear-specific Meis2 knockout leads to aberrant cochlear duct coiling. ChIP-seq of an otic cell line combined with transcriptomics identified direct candidate Meis2 target genes in cochlear morphogenesis.\",\n      \"method\": \"Tissue-specific conditional knockout mice (hindbrain and inner-ear specific Cre lines), RNA-seq of Meis2 mutant otic vesicles, ChIP-seq in otic cell line\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific conditional KOs with defined phenotypes, ChIP-seq for direct targets, multiple orthogonal methods in single study\",\n      \"pmids\": [\"34124068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Dlx1/2 drives Meis2 expression in the lateral ganglionic eminence (LGE) subventricular zone through enhancer hs599; Meis2 directly binds the Zfp503 and Six3 promoters and is required for their expression to specify D1 and D2 medium-sized spiny neurons (MSNs) respectively; Meis2 deletion causes a large reduction in striatal MSNs due to a block in differentiation.\",\n      \"method\": \"Conditional knockout mouse (Meis2fl/fl), ChIP (direct binding to Zfp503 and Six3 promoters), in situ hybridization, Dlx1/2 knockout epistasis, enhancer hs599 characterization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP demonstrating direct target binding, conditional KO with differentiation block phenotype, genetic epistasis with Dlx1/2, multiple orthogonal methods\",\n      \"pmids\": [\"35156680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Meis2 is a direct substrate of the intracellular protease calpain-2 (CAPN2/CAPNS1 complex); phosphorylation at conserved serine/threonine residues or dimerization with PBX1 reduces MEIS2 sensitivity to calpain-2 cleavage. Calpain-2 activity is high in SVZ stem/progenitor cells and declines during neuronal differentiation, inversely correlated with MEIS2 full-length stability; blocking calpain-2 or expressing cleavage-insensitive MEIS2 increases neuron production.\",\n      \"method\": \"In vitro calpain-2 cleavage assay (reconstituted), phosphorylation site mutagenesis, Co-IP (PBX1 dimerization), immunofluorescence in adult V-SVZ, calpain-2 overexpression/inhibition in progenitor cells, cleavage-insensitive MEIS2 overexpression\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstituted cleavage assay, site-directed mutagenesis, Co-IP, and in vivo neurogenic functional readout, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"38305737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Meis2 is specifically expressed in cutaneous low-threshold mechanoreceptors (LTMRs) in mice, dependent on target-derived signals; LTMRs lacking Meis2 survive and are normally specified but show markedly impaired end-organ innervation morphology, altered electrophysiological properties, and an altered transcriptome, resulting in impaired sensory-evoked behavioral responses.\",\n      \"method\": \"Conditional knockout mouse (LTMR-specific Cre lines), in vivo electrophysiology, behavioral touch response assays, immunofluorescence for end-organ morphology, RNA-seq\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific conditional KO with electrophysiological and behavioral phenotypes, RNA-seq, multiple orthogonal methods in single study\",\n      \"pmids\": [\"38386003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"OGT-mediated O-GlcNAcylation of MEIS2 at serine 237 maintains MEIS2 protein stability by inhibiting its ubiquitination; reduced O-GlcNAcylation leads to increased MEIS2 ubiquitination and degradation, impairing osteogenic homeostasis in palatal development.\",\n      \"method\": \"O-GlcNAc-IP, site-directed mutagenesis (Ser237), ubiquitination assay, zebrafish OGT loss-of-function model, Western blot for protein stability, cleft palate mouse model\",\n      \"journal\": \"International journal of oral science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — O-GlcNAcylation site identified by mutagenesis, ubiquitination assay showing stability regulation, in vivo zebrafish model, single lab\",\n      \"pmids\": [\"41936590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CDK4/6 inhibition accelerates displacement of MEIS2 from CRBN by IMiDs and destabilizes MEIS2 protein while increasing CRBN, enhancing CRL4CRBN-mediated ubiquitination of IKZF3 and IKZF1 for degradation; MEIS2 also promotes BCMA expression and antagonizes IMiD/CELMoD-mediated BCMA repression in myeloma cells.\",\n      \"method\": \"Biochemical displacement assay (MEIS2-CRBN), protein stability assays, ubiquitination assays for IKZF1/3, BCMA expression analysis, ex vivo primary bone marrow myeloma cell experiments with CDK4/6 inhibitors and IMiDs\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical binding/displacement and ubiquitination assays with functional ex vivo validation, preprint not yet peer-reviewed\",\n      \"pmids\": [\"41279046\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In developing neocortex, Rbfox proteins induce a progenitor-to-neuron isoform switch in Meis2; the progenitor isoform of Meis2 promotes Tgfb3 transcription, while the neuron isoform promotes neuronal differentiation, demonstrating that alternative splicing of Meis2 generates functionally distinct isoforms with different transcriptional targets.\",\n      \"method\": \"Cell-type-specific RNA-seq, Rbfox1/2/3 conditional triple knockout in neocortex, Meis2 isoform overexpression with Tgfb3 promoter reporter assay, neuronal migration assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — isoform-specific overexpression with reporter assay demonstrating differential transcriptional targets, Rbfox triple KO for splicing mechanism, preprint\",\n      \"pmids\": [\"bio_10.1101_2024.09.09.612108\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"MEIS2 is a TALE-class homeodomain transcription factor that functions primarily as a transcriptional activator (through a C-terminal activation domain subject to autoinhibition by its Hth domain) by forming context-dependent complexes with PBX1, Pax6, Dlx2, Otx2, Pax3/7, Klf4, and PDX1 to regulate target genes (including doublecortin, tyrosine hydroxylase, Zfp503, Six3, SHOX2, FOXM1, and osteogenic genes); its activity and stability are controlled post-translationally by arginine methylation (which impairs CRM1-mediated nuclear export to promote neuronal differentiation), O-GlcNAcylation at Ser237 (which inhibits ubiquitination and stabilizes the protein), calpain-2-mediated proteolytic cleavage (reduced by PBX1 dimerization or phosphorylation), and by the CRL4-cereblon E3 ubiquitin ligase whose access is modulated by IMiDs; in development, Meis2 is epigenetically repressed in distal limb and early embryo by PRC1/RING1B complexes and activated in the midbrain by a tissue-specific enhancer-promoter topological interaction; it plays essential roles in proximal limb identity, cranial and cardiac neural crest development, striatal MSN fate specification, adult SVZ neurogenesis, inner ear morphogenesis, and sensory mechanoreceptor end-organ innervation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MEIS2 is a TALE-class homeodomain transcription factor that assembles context-dependent regulatory complexes to control cell-fate specification across multiple developmental programs [#0, #7]. It functions principally as a transcriptional activator whose C-terminal activation domain is autoinhibited by its homothorax (Hth) domain, an autoinhibition partially relieved by PBX1 binding, while splice variants disrupting the Hth domain or homeodomain can derepress activation or act as dominant negatives [#2, #4]. Through DNA binding and partner-dependent complexes with PBX1/PDX1, Pax6/Dlx2, Otx2, Pax3/7, Klf4, and SHOX2, MEIS2 directs distinct transcriptional outputs—switching PDX1 activity in pancreatic acinar cells [#0], relieving Otx2 repression by competing with Groucho co-repressors during tectal development [#3], activating doublecortin and tyrosine hydroxylase in olfactory-bulb neurogenesis [#7], and binding Zfp503 and Six3 promoters to specify striatal medium-spiny-neuron identity [#23]. In limb development MEIS2 establishes proximal identity that antagonizes distal outgrowth and is spatially restricted by PRC1/RING1-mediated epigenetic repression in the distal bud, a repression axis genetically required for proximal-distal patterning [#1, #10, #15]; its midbrain activation depends on a tissue-specific enhancer-promoter topological switch controlled by RING1 [#8]. MEIS2 is essential for cranial and cardiac neural crest development, palatal and craniofacial skeletogenesis via direct regulation of osteogenic genes and SHOX2, inner ear morphogenesis, and end-organ innervation by cutaneous mechanoreceptors [#11, #20, #21, #22, #25]. Its abundance and localization are tuned post-translationally: arginine methylation impairs CRM1-mediated nuclear export to promote neuronal differentiation [#14], calpain-2 cleaves MEIS2 unless protected by phosphorylation or PBX1 dimerization [#24], O-GlcNAcylation at Ser237 blocks ubiquitination to stabilize the protein [#26], and the CRL4-cereblon E3 ligase targets MEIS2 in a manner modulated by IMiDs [#18]. In disease contexts MEIS2 promotes neuroblastoma mitotic progression through FOXM1 [#9] and collaborates with AML1-ETO leukemogenesis [#12].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established that MEIS2 is not a solitary DNA-binding factor but a combinatorial partner that reprograms the activity of a co-bound homeodomain protein, defining its mechanistic mode of action.\",\n      \"evidence\": \"Co-IP, EMSA, and reporter assays on the pancreatic elastase I enhancer in acinar versus beta-cell lines\",\n      \"pmids\": [\"9710595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define MEIS2's intrinsic activation/repression contribution separate from PDX1/PBX1\", \"Restricted to pancreatic acinar context\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Placed MEIS2 in a developmental patterning role, showing it confers proximal limb identity and antagonizes distal outgrowth downstream of BMP and Hox cues.\",\n      \"evidence\": \"Retroviral misexpression in chick limb buds with distal-marker readouts and BMP/Hoxd epistasis\",\n      \"pmids\": [\"10619030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Gain-of-function only; endogenous requirement not tested here\", \"Direct target genes in limb not identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined MEIS2 as a direct, sequence-specific transcriptional activator and revealed that splice variants and competitor TGIF modulate this activity, including a dominant-negative isoform.\",\n      \"evidence\": \"EMSA, luciferase reporters across isoforms, and dominant-negative overexpression on the dopamine D1A receptor promoter\",\n      \"pmids\": [\"10764806\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological roles of individual isoforms not established\", \"TGIF competition not validated in vivo\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Resolved the molecular basis of MEIS2 transcriptional control by showing the Hth domain autoinhibits the activation domain and PBX1 binding relieves it.\",\n      \"evidence\": \"Domain deletion/fusion constructs, Gal4 activation assays, and Co-IP for Pbx1 interaction\",\n      \"pmids\": [\"20553494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mechanism of autoinhibition not solved\", \"Whether all partner complexes relieve autoinhibition similarly unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed MEIS2 can act by relieving repression—competing with a Groucho co-repressor for Otx2—broadening its mechanistic repertoire beyond direct activation.\",\n      \"evidence\": \"Reciprocal Co-IP, Otx2-dependent reporter, and in ovo electroporation in chick mesencephalon\",\n      \"pmids\": [\"19736326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target genes downstream of Otx2 derepression not mapped\", \"Single developmental context\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified MEIS2 as a cell-autonomous driver of adult SVZ neurogenesis and named its first direct neuronal targets, linking the factor to dopaminergic neuron generation.\",\n      \"evidence\": \"Co-IP for a Meis2-Pax6-Dlx2 complex, ChIP for doublecortin/TH targets, and retroviral loss-of-function in vivo\",\n      \"pmids\": [\"24284204\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target set not defined here\", \"Stoichiometry of the tripartite complex unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed how MEIS2 itself is transcriptionally controlled by a RING1-dependent enhancer-promoter topological switch during midbrain activation.\",\n      \"evidence\": \"ChIP, 3C chromatin conformation capture, and Ring1B conditional knockout mouse\",\n      \"pmids\": [\"24374176\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Factors triggering RBS dissociation unknown\", \"Generality of the topological switch to other tissues untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established a genetic PRC1-MEIS2 repression axis required for proximal-distal limb specification, with RA-related signals competing to polarize Meis2 expression.\",\n      \"evidence\": \"Ring1A/B and PCGF3/5 conditional knockouts, Meis2 compound-mutant rescue, ChIP, and RA pathway epistasis\",\n      \"pmids\": [\"26674308\", \"30190278\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PRC1 recruitment mechanism at the Meis2 locus incompletely defined\", \"Quantitative threshold of Meis2 derepression needed for distal defects unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated an essential requirement for MEIS2 in neural crest derivatives, with loss causing craniofacial, cardiac outflow, and cranial nerve defects and systemic loss being embryonic-lethal.\",\n      \"evidence\": \"AP2\\u03b1-IRES-Cre and systemic Meis2 knockout mice with histology and immunofluorescence\",\n      \"pmids\": [\"26545946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct neural-crest target genes not identified in this study\", \"Cause of embryonic lethality/hemorrhage not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Provided genome-wide direct target maps in palatal neural crest, identifying SHOX2 as both partner and target and tying MEIS2 to osteogenic gene regulation and Shh-dependent arch patterning.\",\n      \"evidence\": \"ChIP-seq, ATAC-seq, RNA-seq, Co-IP, and Wnt1-Cre conditional knockouts with palatal/arch phenotypes\",\n      \"pmids\": [\"32169905\", \"32616504\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MEIS2-SHOX2 co-occupancy is direct cooperative binding at all sites unresolved\", \"Link between Shh loss and downstream ossification incompletely mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined MEIS2's role in striatal MSN fate, showing it acts downstream of Dlx1/2 via enhancer hs599 and directly binds Zfp503 and Six3 to specify D1/D2 neuron identity.\",\n      \"evidence\": \"Meis2 conditional knockout, ChIP for direct promoter binding, and Dlx1/2 epistasis\",\n      \"pmids\": [\"35156680\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single factor selects D1 versus D2 programs not resolved\", \"Cofactors at Zfp503/Six3 promoters not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended MEIS2's organogenesis roles to inner ear formation and cochlear duct coiling with tissue-specific direct candidate targets.\",\n      \"evidence\": \"Hindbrain- and inner-ear-specific conditional knockouts, RNA-seq, and ChIP-seq in an otic cell line\",\n      \"pmids\": [\"34124068\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional validation of individual otic targets pending\", \"Cell-autonomous versus hindbrain-relayed requirement partially separated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed MEIS2 governs cutaneous mechanoreceptor maturation, controlling end-organ innervation, electrophysiology, and touch behavior without affecting neuron survival.\",\n      \"evidence\": \"LTMR-specific conditional knockouts with electrophysiology, behavior, morphology, and RNA-seq\",\n      \"pmids\": [\"38386003\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets driving innervation morphology not identified\", \"Target-derived signal controlling Meis2 expression unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified arginine methylation as a post-translational switch that retains MEIS2 in the nucleus by blocking CRM1 export, coupling the PTM to neuronal differentiation.\",\n      \"evidence\": \"Site-directed methylation mutagenesis, Co-IP of CRM1/PBX1, and subcellular fractionation in SVZ progenitors\",\n      \"pmids\": [\"29641989\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Methyltransferase responsible not identified\", \"Whether methylation alters DNA binding or only localization unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established calpain-2 proteolysis as a determinant of MEIS2 full-length stability during neurogenesis, with phosphorylation or PBX1 dimerization protecting against cleavage.\",\n      \"evidence\": \"Reconstituted in vitro cleavage assay, phospho-site mutagenesis, Co-IP, and calpain-2 manipulation in V-SVZ progenitors\",\n      \"pmids\": [\"38305737\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cleavage products' fate and any function not characterized\", \"Kinase mediating protective phosphorylation not identified\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Showed O-GlcNAcylation at Ser237 stabilizes MEIS2 by blocking ubiquitination, linking nutrient-sensing glycosylation to palatal osteogenic homeostasis.\",\n      \"evidence\": \"O-GlcNAc-IP, Ser237 mutagenesis, ubiquitination assays, and zebrafish OGT loss-of-function\",\n      \"pmids\": [\"41936590\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase opposing this PTM in palate not identified\", \"Crosstalk with calpain and CRBN pathways untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified MEIS2 as a cereblon (CRL4-CRBN) substrate whose IMiD-blockable binding links it to therapeutic E3-ligase modulation and Cyclin E regulation in myeloma.\",\n      \"evidence\": \"Crystal-structure substrate identification, RNAi knockdown, and viability/apoptosis assays\",\n      \"pmids\": [\"30975979\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo physiological role of CRBN-mediated MEIS2 turnover unknown\", \"Degron determinants on MEIS2 not fully mapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected MEIS2 to mitotic gene control in cancer, showing it activates the MuvB-BMYB-FOXM1 program with FOXM1 as a direct target required for neuroblastoma survival.\",\n      \"evidence\": \"siRNA/overexpression with M-phase readouts, ChIP for FOXM1, and rescue experiments\",\n      \"pmids\": [\"25210800\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the FOXM1 axis operates in normal proliferating cells unclear\", \"Upstream control of MEIS2 in neuroblastoma not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed MEIS2 binds the AML1-ETO Runt domain and collaborates in leukemogenesis by relieving AML1-ETO repressive DNA binding and inducing YES1.\",\n      \"evidence\": \"Co-IP of the Runt-domain interaction, shRNA knockdown in AML lines, and a murine leukemia model\",\n      \"pmids\": [\"27346355\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MEIS2 binding sites genome-wide in AML not mapped\", \"Single lab; reciprocal validation limited\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended the MEIS2-CRBN axis to show CDK4/6 inhibition accelerates IMiD-driven MEIS2 displacement and destabilization, enhancing IKZF degradation and modulating BCMA in myeloma.\",\n      \"evidence\": \"Biochemical displacement and ubiquitination assays with ex vivo primary myeloma cells (preprint)\",\n      \"pmids\": [\"41279046\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not yet peer-reviewed\", \"Mechanism by which CDK4/6 inhibition raises CRBN unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How alternative splicing generates functionally distinct MEIS2 isoforms with different transcriptional targets across cell-state transitions remains incompletely defined.\",\n      \"evidence\": \"Open question integrating isoform-specific functions (e.g., Rbfox-driven progenitor-to-neuron switch and PTBP1/MEIS2-L in cancer)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full target repertoires of distinct isoforms unmapped\", \"Whether PTM regulation differs between isoforms unknown\", \"In vivo phenotypic consequences of isoform balance largely untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 5, 7, 9, 23]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 7, 20, 23]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [2, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [14]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [8, 20, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 7, 23]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 11, 20, 22, 25]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [8, 10, 15]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [5, 9, 19]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [14, 18, 24, 26]}\n    ],\n    \"complexes\": [\n      \"MEIS2-PBX1-PDX1 trimeric complex\",\n      \"MEIS2-Pax6-Dlx2 complex\",\n      \"CRL4-cereblon (CRBN) E3 ubiquitin ligase (as substrate)\"\n    ],\n    \"partners\": [\n      \"PBX1\",\n      \"PDX1\",\n      \"Pax6\",\n      \"Dlx2\",\n      \"Otx2\",\n      \"Klf4\",\n      \"SHOX2\",\n      \"CRM1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}